Dr. Yoo described an interesting EEG rhythm, B(I)RDs (Brief potentially Ictal Rhythmic Discharges) in adult population and is continuing her research to find its role as a potential EEG biomarker for seizure activity and the seizure onset zone with scalp and intracranial EEGs.
Mechanisms of EEG Rhythmicity
Dr. Yoo is also interested in the mechanisms of EEG rhythmicity and further development of therapies/clinical trials for drug-resistant epilepsy.
Education
MD, Ewha Women's University
Internship, Internal Medicine, University of Missouri Health Sciences Center
Residency, Neurology, Mount Sinai Hospital
Fellowship, Epilepsy, Yale New Haven Hospital, York Street Campus
Certifications
American Board of Psychiatry and Neurology
Honors & Awards
2016
Teaching award for Outstanding Teaching
Icahn School of Medicine
2019
Fellowship award
NeuroNEXT
2021
Senior-authored abstract/poster received a Young Investigator Award
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Yoo during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Yoo during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.